Amalgamated Bank Intra Cellular Therapies, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 6,888 shares of ITCI stock, worth $577,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,888

Previous 6,922 0.49%

Holding current value

$577,765

Previous $474,000 6.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$67.99 - $80.84 $2,311 - $2,748	-34 Reduced 0.49%	6,888 $504,000
Q2 2024 Aug 12, 2024	BUY	$64.76 - $79.84 $241,943 - $298,282	3,736 Added 117.26%	6,922 $474,000
Q1 2024 Apr 23, 2024	SELL	$64.37 - $75.65 $657,088 - $772,235	-10,208 Reduced 76.21%	3,186 $220,000
Q4 2023 Feb 06, 2024	SELL	$46.37 - $73.65 $43,263 - $68,715	-933 Reduced 6.51%	13,394 $959,000
Q3 2023 Nov 08, 2023	BUY	$52.09 - $64.1 $7,917 - $9,743	152 Added 1.07%	14,327 $746,000
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $64,893 - $78,864	1,187 Added 9.14%	14,175 $897,000
Q1 2023 May 02, 2023	SELL	$43.8 - $56.99 $89,702 - $116,715	-2,048 Reduced 13.62%	12,988 $703,000
Q4 2022 Feb 10, 2023	BUY	$44.07 - $54.45 $9,386 - $11,597	213 Added 1.44%	15,036 $796,000
Q3 2022 Nov 09, 2022	BUY	$42.7 - $59.99 $6,874 - $9,658	161 Added 1.1%	14,823 $690,000
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $64,070 - $97,803	1,490 Added 11.31%	14,662 $837,000
Q1 2022 Jun 30, 2022	BUY	$38.74 - $62.09 $28,435 - $45,574	734 Added 5.9%	13,172 $806,000
Q4 2021 Feb 15, 2022	SELL	$35.2 - $53.42 $4,752 - $7,211	-135 Reduced 1.07%	12,438 $651,000
Q3 2021 Oct 29, 2021	SELL	$28.72 - $42.49 $22,200 - $32,844	-773 Reduced 5.79%	12,573 $469,000
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $188,721 - $286,624	6,441 Added 93.28%	13,346 $545,000
Q1 2021 May 13, 2021	SELL	$30.8 - $39.51 $18,202 - $23,350	-591 Reduced 7.88%	6,905 $234,000
Q4 2020 Feb 12, 2021	BUY	$23.34 - $32.22 $174,956 - $241,521	7,496 New	7,496 $238,000
Q1 2020 May 13, 2020	SELL	$12.31 - $33.12 $98,590 - $265,258	-8,009 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$7.26 - $38.49 $58,145 - $308,266	8,009 New	8,009 $275,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Intra Cellular Therapies, Inc. Transaction History